Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Weight Loss in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

May 15, 2024

Study Completion Date

June 3, 2024

Conditions
Obesity
Interventions
OTHER

Control Group

Participants receive DS prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.

OTHER

AI-Guided Group

Participants receive DS prescriptions determined by an AI system, which considers genetic data, metabolic profiles, biochemical markers, and patient history.

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER

NCT06458296 - Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Weight Loss in Obese Patients | Biotech Hunter | Biotech Hunter